ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2690

Potential Markers of Skin Involvement in Systemic Sclerosis

Radim Becvar1, Hana Storkanova2, Barbora Sumova1, Maja Spiritovic1, Sabina Oreska2, Ladislav Šenolt1 and Michal Tomcik2, 1Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 2Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Biomarkers, skin fibrosis and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Skin fibrosis is a hallmark of systemic sclerosis (SSc). There are no widely accepted biomarkers of skin involvement in this condition. Several serum or plasma markers have been studied in patients with SSc – monocyte chemoattractant protein-1 (MCP-1), chemokine (C-X-C motif) ligand 8 (CXCL8), interleukin-13 (IL-13), and some more recognized such as – platelet derived growth factor (PDGF), transforming growth factor-beta 1 (TGF-beta 1), epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). The aim of this study was to assess several circulating biomarkers which may be relevant to the fibrosing process and further to correlate the obtained data with clinical indicators specific for SSc skin involvement.

Methods:

59 SSc patients (M/F 9/50; mean age 52.1 years, mean disease duration 6.7 years, 36 patients with limited cutaneous SSc and 23 with diffuse cutaneous SSc. As a control group 36 healthy individuals matched to sex and age were examined.

Serum concentrations of bFGF, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor (GM-CSF), MCP-1, PDGF, IL-8 and 13 were analysed using commercial multiplex kit. The following clinical examinations were performed: modified Rodnan skin score (mRSS), Hand Mobility in Scleroderma Test (assessing hand function) (HAMIS), Cochin Hand Function Scale (hand function) (CHFS), Delta Finger-to-Palm Distance (extension-flexion) (dFTP), Inter-lip Distance (inter-lip), Inter-incisor Distance (inter-incisor), and Mouth Handicap in Systemic Sclerosis Scale (mouth opening) (MHISS). For statistical evaluation Spearman’s correlation coefficient was used.

Results:

When compared with healthy controls serum concentrations of bFGF (p<0.001), G-CSF (p<0.0001), GM-CSF (p<0.0001), MCP-1 (p<0.0001) IL-8 (p<0.0001), and IL-13 (p<0.001) were significantly elevated in SSc cohort . PDGF levels were increased in SSc patients with only a lower significance (p<0.01).

bFGF, G-CSF, MCP-1 and IL-8 levels correlated significantly (p<0.05) with mRSS and HAMIS. GM-CSF levels correlated with mRSS and HAMIS and there was only a trend for negative correlation with inter-incisor. The was no correlation of IL-13 and PDGF levels with the evaluated clinical data.

Conclusion:

Our results have shown that G-CSF, GM-CSF and IL-8 play a substantial role in SSc fibrosing process. Potential biomarkers as bFGF, G-CSF, MCP-1 and IL-8 correlated with a few clinical indices of SSc skin involvement.

Acknowledgement: Study was supported by research grants AZV 16-33574A and AZV 16-33542A.


Disclosure: R. Becvar, None; H. Storkanova, None; B. Sumova, None; M. Spiritovic, None; S. Oreska, None; L. Šenolt, None; M. Tomcik, None.

To cite this abstract in AMA style:

Becvar R, Storkanova H, Sumova B, Spiritovic M, Oreska S, Šenolt L, Tomcik M. Potential Markers of Skin Involvement in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/potential-markers-of-skin-involvement-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/potential-markers-of-skin-involvement-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology